Variant report
Variant | nsv963953 |
---|---|
Chromosome Location | chr2:142099944-142113927 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565171742 | chr2:142106237-142106238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143669985 | chr2:142106239-142106240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs61393938 | chr2:142106269-142106270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530839660 | chr2:142106271-142106272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148164979 | chr2:142106291-142106292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570065755 | chr2:142106318-142106319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142034525 | chr2:142106322-142106323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566148387 | chr2:142106335-142106336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534531541 | chr2:142106352-142106353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1521105 | chr2:142106368-142106369 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs1521106 | chr2:142106371-142106372 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs543697207 | chr2:142106425-142106426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556579180 | chr2:142106451-142106452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576414543 | chr2:142106453-142106454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545523026 | chr2:142106454-142106455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373001076 | chr2:142106464-142106465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1521107 | chr2:142106476-142106477 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs146155137 | chr2:142106485-142106486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs386651226 | chr2:142106523-142106524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2683821 | chr2:142106524-142106525 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs557534112 | chr2:142106529-142106530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569312104 | chr2:142106542-142106543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:142106200-142106600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |